Indian clinical practice consensus guidelines for the management of oropharyngeal cancer

Prabhash, Kumar; Babu, Govind; Chaturvedi, Pratibha; Kuriakose, Moni Abraham; Birur, Praveen; Anand, AnilK; Kaushal, Ashish; Mahajan, Abhishek; Syiemlieh, Judita; Singhal, Manish; Gairola, Munish; Ramachandra, Prakash; Goyal, Sumit; John, Sheila; Nayyar, Rohit; Patil, VijayM; Rao, Vishal; Roshan, Vikas; Rath, GK

doi:10.4103/0019-509x.278976

Cited by 7 publications

(10 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…National guidelines do not emphasise oral dental care integration in detail [10][11][12]. Hence, a supportive oral care protocol is essential for addressing this essential aspect of cancer care in head and neck cancer patients.…”

Section: Discussionmentioning

confidence: 99%

Validation of a Novel ‘Supportive Oral Care Protocol’ (SOCP), a Model for Care in Head and Neck Cancer Patients at Tertiary Cancer Centre in India

Kandwal

Saini

Ahmad

et al. 2020

Indian J Surg Oncol

View full text Add to dashboard Cite

India has a huge burden of head and neck cancer and specifically oral cancer. Supportive oral care is not a standard of care in our population and is often neglected. Currently, there are no specific guidelines for such care in India which could be followed. The aim of this study is to validate a novel institutional supportive oral care protocol (SOCP) for head and neck cancer patients. This protocol is specific to our population developed for head and neck/dental oncology experts working in cancer centres to provide comprehensive care. This is a cross-sectional validity study. Fifteen dental oncology experts working in cancer centres/hospitals across India and six oncology experts from our centre were enrolled. All experts provided their inputs on 41 points of the SOCP. The data was analysed for item validity, content validity index and inter-rater agreement. The statistical analyses used were kappa measure for inter-rater agreement and content validity index for item-wise agreement. Out of 861 responses from all the reviewers, 91% agreed, 8.4% agreed with modification and 0.6% disagreed. The content validity index and agreement between reviewers ranged from 0.9 to 1 for kappa measure. The SOCP of our institution was shown to be a valid protocol. SOCP addresses oral and dental supportive care and rehabilitation as part of overall comprehensive care for head and neck cancer patients in our population.

show abstract

Section: Discussionmentioning

confidence: 99%

Validation of a Novel ‘Supportive Oral Care Protocol’ (SOCP), a Model for Care in Head and Neck Cancer Patients at Tertiary Cancer Centre in India

Kandwal

Saini

Ahmad

et al. 2020

Indian J Surg Oncol

View full text Add to dashboard Cite

show abstract

“…A total of 25 CPGs were published between 1996 and 2023, 10 of them with algorithms guiding the recommendations [13,15,16,18,21,27,31,35,37,38]. CPGs with constant updates were observed in societies such as the Spanish Society of Medical Oncology (SEOM), American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), National Comprehensive Cancer Network (NCCN), and the American College of Radiology Appropriateness Criteria (ACR-AC).…”

Section: Guideline Characteristicsmentioning

confidence: 99%

“…CPGs with constant updates were observed in societies such as the Spanish Society of Medical Oncology (SEOM), American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), National Comprehensive Cancer Network (NCCN), and the American College of Radiology Appropriateness Criteria (ACR-AC). A total of 15 CPGs reported the TNM editions used for recommendations, 1 from the fifth edition (1997) [18], 6 from the seventh edition (2009) [22,23,25,28,30,32], and 8 from the eighth edition (2017) [13,15,16,21,27,31,35,38]. Three European CPGs used the Infectious Diseases Society of America-US Public Health Service Grading System for ranking strength of recommendations and quality of evidence score [13,27,31].…”

Section: Guideline Characteristicsmentioning

confidence: 99%

Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide

Arboleda,

de Carvalho,

Santos-Silva

et al. 2023

Cancers

View full text Add to dashboard Cite

Head and neck cancer (HNC) treatments have been based on single or multimodal therapies with surgery, radiotherapy (RT), chemotherapy, and immunotherapy. However, treatment recommendations among countries may differ due to technological/human resources and usual local practices. This scoping review aims to identify, compare, and map the clinical practice guidelines (CPGs) for treating squamous cell carcinoma (SCC) of the oral cavity, oropharynx, and larynx worldwide. A search strategy on global CPGs for HNC was performed by using five electronic databases and grey literature. CPGs were selected for inclusion using EndNote-20 and Rayyan online software. No language or publication date restrictions were applied. The results were analyzed descriptively considering the most updated CPG version. In total, 25 CPGs covering the head and neck region (10), the larynx (7), the oral cavity (5), and the oropharynx (3), were found in 13 geographical regions, and 19 were developed by medical societies from 1996 to 2023. Surgery and RT remain the main modalities for early-stage HNC, with surgery preferred in low-resource countries, and RT in selected cases, especially in the larynx/oropharynx aiming to achieve a cure with organ preservation. Human papillomavirus infection for oropharyngeal SCC is not tested in some Asian countries and there is still no consensus to treat p16-positive cases differently from p16-negative. Recommendations for larynx preservation vary according to facilities in each country, however, individualized choice is emphasized. Inequality across countries/continents is evident, with a similar pattern of recommendations among developed as well as developing ones. No CPGs were found in Latin America as well as Oceania countries, where the incidence of HNC is high and limitations of access to treatment may be encountered.

show abstract

“…The primary treatment is transoral or open resection or definitive radiotherapy or concurrent chemoradiotherapy depending on disease stage. 22 Patients with stage II and higher disease benefit from the addition of concurrent cisplatin. In a randomized phase II trial, 40 mg/m 2 of cisplatin once a week concurrently with radiotherapy improved oncologic outcomes; the 3-year overall survival and the median overall survival were 62%/not reached versus 42%/27 months (95% CI, 15.2-36.8) in patients treated with concurrent chemoradiotherapy versus radical radiotherapy, respectively.…”

Section: Curative Settingmentioning

confidence: 99%

Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer

Fagan

Noronha

Graboyes

2021

American Society of Clinical Oncology Educational Book

View full text Add to dashboard Cite

The overwhelming majority of head and neck cancers and related deaths occur in low- and middle-income countries, which have challenges related to burden of disease versus access to care. Yet the additional health care burden of the COVID-19 pandemic has also impacted access to care for patients with head and neck cancer in the United States. This article focuses on challenges and innovation in prioritizing head and neck cancer care in Sub-Saharan Africa, the Indian experience of value-added head and neck cancer care in busy and densely populated regions, and strategies to optimize the management of head and neck cancer in the United States during the COVID-19 pandemic.

show abstract

Indian clinical practice consensus guidelines for the management of oropharyngeal cancer

Cited by 7 publications

References 23 publications

Validation of a Novel ‘Supportive Oral Care Protocol’ (SOCP), a Model for Care in Head and Neck Cancer Patients at Tertiary Cancer Centre in India

Validation of a Novel ‘Supportive Oral Care Protocol’ (SOCP), a Model for Care in Head and Neck Cancer Patients at Tertiary Cancer Centre in India

Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide

Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer

Contact Info

Product

Resources

About